Toray and Spectral Medical Inc. are seeking Premarket Approval from the FDA for a PMX product.
5 reports, 2 independent
Updated Sep 11
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 5
- Developments
- 1
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Toray and Spectral Medical Inc. are seeking Premarket Approval from the FDA for a PMX product.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- FDA and Pfizer are seeking regulatory approval for their products.
- Philip Morris International marketed products and issued MRTP orders for ZYN products under U.S. authorization.
- FDA granted Priority Review for the BLA submission of the SkinTE product.
- The FDA and Intellia Therapeutics are preparing a regulatory filing for product approval.
- NRx Pharmaceuticals and TMS are undergoing various reviews with the FDA, including guidance on real-world evidence and a ketamine ANDA review.